National Institutes of Health
Sanofi research czar Elias Zerhouni has pushed for the company to delve deeply into the study of diseases before leaping into drug development. Now the French drug giant plans to collaborate with the software company NextBio to infuse patients' genomic and other data into its work on treatments for such diseases as cancer and diabetes.
The federal government has put the brakes on the largest and most advanced study of a vaccine against HIV infection after an independent data and safety monitoring board found that the vaccine regimen did not benefit patients.
A researcher at the Icahn School of Medicine at Mount Sinai has won a $5 million grant from the National Institutes of Health to investigate diagnostic biomarkers of spasmodic dysphonia, a rare neurological disorder that affects the vocal chords.
President Barack Obama is poised to launch a public-private initiative aimed at mapping the human brain, called the Brain Activity Map.
The prescription Auvi-Q injection device, now available in the U.S. from Sanofi, provides step-by-step instructions for the user that include audible and visual cues and an injection countdown.
In the latest push to better predict, diagnose and monitor Parkinson's disease, the National Institute of Neurological Disorders and Stroke, part of NIH, is launching a new online collaborative resource that will support data-sharing in an effort to find biomarkers for the disease.
Scientists at the National Cancer Institute, part of the National Institutes of Health, have developed a new gene that interferes with the clearance of hepatitis C infection.
The complement receptor-1 (CR1) gene has recently been linked with the risk of late-onset Alzheimer's disease. Researchers from the National Institute on Aging (NIA) at the National Institutes of Health have found that a variant in the gene affects the levels of beta amyloid in the brains of cognitively healthy older people.
While it is not mentioned in the announcement, the drug-resistant superbug that has now killed 7 people infected at the National Institutes of Health Clinical Center had to be on the mind of FDA officials when they decided to form a task force to help push antibacterial drug development.
Researchers from Columbia University Medical Center (CUMC) have found potential biomarkers and drug targets for the more common, non-inherited form of Parkinson's disease.